Mineralys Therapeutics (MLYS) Earnings Date & Reports

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MLYS is expected to report earnings to rise 59.57% to -75 cents per share on November 16

Mineralys Therapeutics MLYS Stock Earnings Reports

Q3'26

Est.

$-0.75

Q1'26

Beat

by $0.34

Q4'25

Beat

by $0.54

Q3'25

Beat

by $0.44

Q2'25

Beat

by $0.40

The last earnings report on May 06 showed earnings per share of -46 cents, beating the estimate of -81 cents. With 399.49K shares outstanding, the current market capitalization sits at 2.49B.

View a ticker or compare two or three

Ask AI

Compare

NEWBiotechnologies - Trading Results
AI Trading Agent, 60min NEWBiotechnologies - Trading Results
AI Trading Agent, 60min

Annualized Return+59%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

MLYS

Setup

Daily Signal:

Description

Gain/Loss: